A cost comparison of GLP-1 receptor agonists and bariatric surgery
All scientific content, interpretation, and conclusions were developed by the authors
showed that release of GLP-1 in response to the intake of glucose is slower in UC patients who underwent colectomy (Palnaes Hansen et al
Second, this analysis focused exclusively on a subset of GLP-1 RA therapies (specifically semaglutide and tirzepatide) and did not account for other common PCOS treatments, such as metformin, combined oral contraceptives, or anti-androgen therapies
31 In a trial evaluating semaglutide for weight loss, the incidence of acute pancreatitis was still low (3 of 1,306 participants) despite a higher dose and more significant weight loss, but none of the 655 individuals in the placebo group developed pancreatitis
Fourth, although the study leveraged a large and diverse U.S.-based population, findings may not be generalizable to other healthcare systems or regions with different prescribing patterns and surveillance intensity
